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Abstract
CHD1 is a SNF2-related ATPase that is required for the genome-wide incorporation of variant histone H3.3 in the paternal
pronucleus as well as in transcriptionally active nuclei in Drosophila embryos. The S. pombe and vertebrate orthologs of
CHD1 have been implicated in the assembly of the centromeric histone H3 variant CenH3
CENP-A, which occurs in a DNA
replication-independent manner. Here, we examined whether CHD1 participates in the assembly of CenH3
CID in Drosophila.
In contrast to the findings in fission yeast and vertebrate cells, our evidence clearly argues against such a role for CHD1 in
Drosophila. CHD1 does not localize to centromeres in either S2 cells or developing fly embryos. Down-regulation of CHD1 in
S2 cells by RNAi reveals unchanged levels of CenH3
CID at the centromeres. Most notably, ablation of functional CHD1 in
Chd1 mutant fly embryos does not interfere with centromere and kinetochore assembly, as the levels and localization of
CenH3
CID, CENP-C and BubR1 in the mutant embryos remain similar to those seen in wild-type embryos. These results
indicate that Drosophila CHD1 has no direct function in the incorporation of the centromeric H3 variant CenH3
CID into
chromatin. Therefore, centromeric chromatin assembly may involve different mechanisms in different organisms.
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Introduction
The incorporation of variants of the histones H3 and H2A, such
as H3.3, CenH3 or H2A.Z, into chromatin correlates with
functional specification of genomic regions and is thought to
contribute to the epigenetic memory of a cell [1]. In contrast to
canonical histones, which are assembled during DNA replication,
histone variants are incorporated into chromatin throughout the
cell cycle. However, a thorough understanding of the mechanisms
of replication-independent assembly of histone variants remains to
be established.
In vitro, the concerted action of histone chaperones and ATP-
utilizing factors is required for histone deposition and nucleosome
arrangement [2,3]. The ATP-dependent motor protein Drosophila
CHD1 mediates the reconstitution of periodic nucleosome arrays
in conjunction with the histone chaperone NAP1 in an in vitro
chromatin assembly system [4]. We have recently shown that in
vivo, CHD1 is required for the replication and transcription-
independent genome-wide assembly of the variant histone H3.3 in
the paternal pronucleus and in transcriptionally active nuclei
during embryonic development [5], thus confirming its role as a
chromatin assembly factor.
Another H3 variant that is incorporated into chromatin in a
replication-independent manner is the centromere-specific histone
CenH3 (also known as CENP-A, CID, Cnp1, Cse4). Centromeres
are specialized regions within eukaryotic chromatin that direct the
faithful segregation of chromosomes during mitosis by serving as
an assembly platform for the kinetochore. Notably, centromeric
DNA sequence composition is not conserved among organisms,
and it is therefore commonly thought that epigenetic mechanisms
determine centromere identity and function [6,7]. A distinguishing
feature of centromeric chromatin in all organisms is the presence
of CenH3-containing nucleosomes [1,8]. CenH3
CENP-A incorpo-
ration occurs during late mitosis and G1 in human cells [9]. In
cleavage-stage Drosophila embryos, in which the cell cycle lacks gap
phases [10], the assembly of CenH3
CID into centromeric
chromatin takes place during anaphase [11].
Two studies have implicated CHD1 in the formation of
centromeric chromatin. In fission yeast, deletion of the CHD1
ortholog Hrp1 was found to result in decreased incorporation of
CenH3
Cnp1 [12]. More recently, it was reported that CHD1
localizes to centromeres throughout the cell cycle in chicken DT40
and in HeLa cells. Furthermore, RNAi-mediated knockdown of
CHD1 led to a loss of CenH3
CENP-A signal intensities at
centromeres suggesting that CHD1 is required for the incorpora-
tion of CenH3
CENP-A [13].
In this study, we examined the function of CHD1 in centromeric
chromatin assembly in Drosophila. In contrast to findings in fission
yeast and vertebrate cells, we observed that Drosophila CHD1 is not
required for CenH3
CID incorporation and kinetochore integrity.
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Dynamic localization pattern of CHD1 in Drosophila cells
Previous reports have demonstrated that CHD1 resides in
the nucleus in mammalian cells during interphase but is
released into the cytoplasm during mitosis [14,15]. Recently,
CHD1 was shown to be present at centromeres throughout the
cell cycle in chicken and human cells [13]. To investigate the
role of Drosophila CHD1 in CenH3
CID incorporation into
chromatin, we examined the potential colocalization of CHD1
with CenH3
CID at centromeres in Drosophila S2 cells. To this
end, we established a stable S2 cell line that allows for
inducible expression of EGFP-tagged CenH3
CID.D e p e n d i n g
on the amount of overexpressed protein, EGFP-CenH3
CID is
incorporated into authentic centromeres but may also form
additional ectopic centromeres [16]. By using an antibody
against the C-terminal portion of Drosophila CHD1 [17] we
observed a granular staining pattern of interphase nuclei in S2
cells and the release of the protein from chromatin into the
cytoplasm during mitosis (Figure 1A). In the majority of
cells (61%; n=54) we did not detect overlaps of CHD1 and
CenH3
CID immunosignals in interphase or during mitosis
(Figure 1A and C). Occasionally, merging signals were
observed in some interphase nuclei. Quantification of these
signals, however, revealed no conspicuous accumulation of
overlapping signals in certain populations of cells, which
might suggest cell cycle-dependent colocalization of CHD1
and EGFP-CenH3
CID (Figure 1C). Moreover, out of 447
CenH3
CID foci evaluated only 31 (6.9%) showed (partial)
overlaps with CHD1 signals. Similar results were obtained
when cells were treated with 0.1% Triton X-100 before
fixation to reduce the amount of CHD1 that is not bound to
chromatin (Figure 1A). In support of these observations, no
overlapping signals of anti-EGFP-CenH3
CID and anti-CHD1
staining were detected on mitotic chromosome spreads of
S2 cells (Figure 1B).
These results are clearly different from the observed colocaliza-
tion of CHD1 and CenH3
CENP-A in vertebrate cells [13]. To rule
out the possibility that our antibody does not recognize CHD1
when it is centromere-bound, we performed the same experiments
with an antibody raised against two CHD1 peptides (Figure S1A
and S2A). Moreover, we examined the localization pattern of
CHD1 in an S2 cell line stably expressing Flag-tagged CHD1
(Figure S1D) by staining with anti-Flag antibodies (Figure S2B).
Both approaches confirmed the absence of CHD1 at centromeric
chromatin regions (Figure S2A and S2B).
We also examined whether there is a physical interaction
between CHD1 and EGFP-CenH3
CID in S2 cells. To this end,
chromatin from S2 cells was extensively digested with micro-
coccal nuclease to preferentially release mononucleosomes
followed by immunoprecipitationw i t he i t h e ra n t i - G F Po ra n t i -
CHD1 antibodies. Subsequent western blot analysis failed to
reveal mutual co-precipitation of the two proteins (Figure 1D).
Thus, in cultured Drosophila cells there is neither a colocalization
of CHD1 and CenH3
CID nor do these proteins show direct or
indirect physical interaction.
Next we examined whether CHD1 colocalizes with CenH3
CID
in vivo. Embryos from flies expressing an EGFP-tagged version of
CenH3
CID [11] were collected at 0–2 h after egg deposition and
analyzed. CHD1 did not colocalize with the centromeres at any
cell cycle stage in syncytial Drosophila embryos (Figure 2 and data
not shown). Hence, we conclude that there are clear differences in
the intranuclear localization of CHD1 between vertebrate and
Drosophila cells.
CHD1 depletion does not affect cell cycle progression
and CenH3
CID loading in S2 cells
The localization pattern of CHD1 might not necessarily reflect
its cellular functions. Thus, low levels of CHD1 that escape
detection by immunofluorescence might be sufficient to allow
functional participation of CHD1 in the CenH3
CID loading
process. To investigate a potential role of CHD1 in the
incorporation of CenH3
CID into centromeric chromatin, we
performed RNAi-mediated knockdown of CHD1 in S2 cells.
Treatment of S2 cells with a combination of two CHD1 dsRNA
probes resulted in the reduction of CHD1 protein expression
below the detection limit (Figures 3A and S1C). We then
examined the occurrence of aberrant mitotic figures and/or
missegregation of chromosomes in S2 cells after various times of
RNAi treatment (2 days – 8 days). Such effects should be expected,
if CHD1 affects CenH3
CID loading and subsequent kinetochore
formation [18,19]. However, the rare incidence of mitotic defects
remained unchanged in CHD1-depleted cells relative to untreated
cells (data not shown). We also analyzed the cell cycle profiles of
RNAi-treated and untreated cells by FACS analysis, but did not
detect any significant alterations in the distribution of the different
cell cycle stages (Figure 3D). Likewise, staining of CHD1-depleted
cells with anti-CenH3
CID antibodies and quantification of the
intensity of CenH3
CID fluorescence signals revealed no reduction
in CenH3
CID levels in cells after 4, 6 or 8 days of RNAi treatment
relative to control cells (Figures 3B and C). In contrast, depletion
of the inner kinetochore component CENP-C, which had been
demonstrated before to be necessary for CenH3
CID loading [20],
caused defects in nuclear morphology (Figures S3A and B) and
,60% reduction in CenH3
CID levels relative to control cells after
4 days of RNAi treatment (Figure S3C). By day 6 of RNAi
treatment most of the cells had died (data not shown).
Despite the fact that CenH3
CID levels at the centromeres were
not altered by CHD1 depletion, it was possible that the association
of CenH3
CID with the chromatin was perturbed in a way similar
to what has recently been reported for human CenH3
CENP-A upon
depletion of the chromatin remodeling complex RSF [21]. To
examine this idea, whole cell lysate, nuclear extracts and
chromatin core fractions were prepared from CHD1-RNAi and
control cells and CenH3
CID levels were quantified on western
blots. These analyses did not show increased solubility of
CenH3
CID in CHD1-depleted versus control cells. In all cellular
fractions CenH3
CID levels were similar in RNAi-treated and
control cells (Figure 3E).
Collectively, these data argue against a functional role for
CHD1 in the deposition or maintenance of CenH3
CID at
centromeres in Drosophila cells. It was possible, however, that
small amounts of CHD1 that were not removed by RNAi-
mediated knockdown prevented the detection of centromeric
chromatin assembly defects. Hence, we investigated centromeric
chromatin formation in Chd1 null mutant fly embryos.
CenH3
CID loading is not compromised in Chd1 mutant
Drosophila embryos
We had previously shown that embryos deposited by Chd1 null
mutant females (Df(2L)Chd1
1/Df(2L)Exel7014) are not viable [5].
The majority of these embryos are arrested at the earliest stages of
development due to their inability to incorporate H3.3 into
paternal chromatin in the absence of CHD1. Some embryos,
however, survive until the syncytial blastoderm and even early
gastrulation stages with haploid, maternally-derived chromosome
content [5]. These embryos are completely devoid of CHD1, since
the mothers do not produce CHD1 and the paternal chromo-
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whether CHD1 is required for CenH3
CID incorporation during
early embryonic development. DNA staining of syncytial embryos
deposited by Df(2L)Chd1
1/Df(2L)Exel7014 females (for simplicity
termed Chd1 null embryos; Figure 4A) revealed mitotic defects,
such as chromosome missegregation, lagging chromosomes or
aberrant spindle appearance, in 15.6% of the mutant embryos
(n=295; Figure 4B, C, D) compared to 1% (n=209) of wild-type
embryos. A small fraction (1.7%) of the mutant embryos also
displayed micro- and macronuclei as well as irregular arrange-
ments of nuclei (Figure 4B). Although these defects could
potentially be due to compromised centromere function, staining
of the embryos with anti-CenH3
CID antibodies did not reveal
aberrant localization or a reduction in CenH3
CID signal intensities
(Figure 5A and B). It is important to note that Chd1-deficient
embryos contain only 4 chromosomes corresponding to the
maternal genome. This is reflected by the appearance of fewer
centromeric foci than in wild-type embryos, which have 8
chromosomes per nucleus. Consistent with our observations in
S2 cells, these data argue that CHD1 does not have an essential
function in centromeric chromatin assembly.
Intact localization of kinetochore components in Chd1
null embryos
The presence of normal CenH3
CID amounts at centromeres in
Chd1 null embryos strongly suggests that CHD1 is not necessary
for CenH3
CID loading onto the DNA. However, CHD1 might still
be involved in the remodeling of centromeric nucleosomes in
order to allow proper kinetochore assembly. Since we have
observed nuclear defects in Chd1 null embryos (see above) that
could potentially be due to compromised kinetochores, we
examined the effect of the absence of CHD1 upon the localization
Figure 1. CHD1 is not present at centromeres in Drosophila S2 cells. A) CHD1 displays nuclear staining during interphase and redistributes to
the cytoplasm during mitosis. S2 cells stably expressing EGFP-tagged CenH3
CID were treated (bottom) or not (top) with Triton X-100 before fixation to
reduce the amount of soluble protein. Cells were stained with anti-CHD1 (red) and anti-GFP (green) antibodies. DNA is shown in blue. B) CHD1 is
absent from chromosomes at metaphase. Spreads of metaphase chromosomes from EGFP-CenH3
CID-expressing S2 cells were stained with antibodies
against CHD1 (red) and GFP (green). C) Quantification of overlapping CHD1 and EGFP-CenH3
CID signals. Percentages of overlapping signals per cell
were calculated and plotted against the percentage of cells displaying similar ratios of overlap. D) CHD1 and EGFP-CenH3
CID do not interact. Co-
immunoprecipitations were performed on micrococcal nuclease treated S2 cell extracts with antibodies against GFP, CHD1 or protein A sepharose
beads only. Aliquots of the input (IN) fraction, supernatant (SN) and eluted beads (B) were subjected to immunoblotting with anti-CID and anti-CHD1
antibodies.
doi:10.1371/journal.pone.0010120.g001
Figure 2. CHD1 and CenH3
CID do not colocalize in Drosophila embryos. Embryos laid by transgenic female flies expressing EGFP-tagged
CenH3
CID [11] were collected at 0–2 h after egg deposition and stained with antibodies against CHD1 (red) and GFP (green) to detect EGFP-CenH3
CID.
DNA was stained with DAPI (blue). Three syncytial embryos with interphase, metaphase and anaphase nuclei, respectively, are shown. CHD1 does not
colocalize with centromeres at any cell cycle stage.
doi:10.1371/journal.pone.0010120.g002
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outer kinetochore component BubRI [22]. Stainings of wild-type
and Chd1 null embryos with antibodies against these proteins
revealed that both proteins were correctly localized to centromeres
(Figure 6A and B).
Thus, the formation of functional kinetochores appears to be
unaffected in the absence of CHD1. These data further support
the conclusion that CHD1 does not contribute in a critical manner
to the functions of CenH3
CID chromatin in Drosophila.
Discussion
Our analysis of the role of the ATP-dependent chromatin
assembly factor CHD1 in centromeric chromatin formation
revealed that Drosophila CHD1 is unlikely to play an important
part in the assembly and/or maintenance of CenH3
CID at the
centromeres. We provide multiple lines of evidence, including a
lack of centromeric localization of CHD1, the absence of
CenH3
CID loading defects in RNAi-treated cells as well as in
Figure 3. Cell cycle progression and CenH3
CID loading are not affected by RNAi-mediated downregulation of CHD1. A) Treatment of
S2 cells with dsRNA targeting CHD1 for 4, 5, 6 and 8 days results in a decrease of CHD1 protein below detection limits. To control for equal loading
western blots were incubated with an antibody against Drosophila ISWI (bottom). A serial dilution of control extracts was used to quantify CHD1
knockdown (right panel). B) CHD1 RNAi treated (4 days) and control cells were stained with anti-CenH3
CID antibodies (green). DNA was
counterstained with DAPI (red). C) Signal intensities of centromeric foci after staining with anti-CenH3
CID antibodies were quantified as described in
Materials and Methods. Error bars denote standard deviations of signals obtained from the following numbers of interphase nuclei: day 4 control and
RNAi, n=29; day 6 control, n=168; day 6 RNAi, n=148; day 8 control, n=208; day 8 RNAi, n=169. Signal intensities remained unchanged despite
extensive CHD1 depletion. D) Cell cycle profiles of CHD1 RNAi treated (+) and untreated (2) control cells were determined by FACS analysis at
different times (days 0–6) of dsRNA incubation. No significant changes in cell cycle progression patterns are detectable. E) Immunoblot analysis of
cellular fractions of control and CHD1 RNAi treated cells with antibodies against CHD1 and CID. CAF-1 p55 was used as a loading control. WCL, whole
cell lysate; NUC, nuclei; NE, high salt nuclear extract; CHR, chromatin core fraction (high salt insoluble fraction). The relative amounts of CID in the
different fractions remain largely unaltered after CHD1-depletion.
doi:10.1371/journal.pone.0010120.g003
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kinetochore components CENP-C and BubRI in Chd1 null
embryos, that strongly argue against a critical function for
CHD1 in this process. These findings stand in contrast to those
from previous studies of CHD1 in S. pombe, chicken and human
cells [12,13]. In hrp1D mutant strains in fission yeast, it was shown
by ChIP that CenH3
Cnp1 levels are substantially reduced, whereas
H3 levels are increased relative to wild-type yeast over the central
core region of the centromeres. Moreover, Hrp1 was found to
colocalize with centromeric regions during G1/S phase [12].
Centromeric localization of CHD1 was also observed in chicken
DT40 cells, and RNAi-mediated depletion of CHD1 in human
cells resulted in a strong decrease in CenH3
CENP-A centromeric
signals [13]. The reasons for the observed differences between
these and our data are unlikely to be technical in nature. Our
results were obtained by multiple distinct approaches, all of which
led to the conclusion that CHD1 does not play a critical role in
CenH3
CID incorporation in Drosophila.
One explanation for that might be that centromeric chromatin
assembly in different organisms might involve distinct mecha-
nisms. This idea is consistent with the high degree of diversity of
centromere organization and kinetochore components among
different species [6]. Moreover, the structure of CenH3 itself
differs considerably between species. Gene evolution studies
revealed that the Drosophila and Arabidopsis CenH3 genes are
subject to adaptive evolution, particularly in the regions that
encode the DNA-interacting Loop 1 [23]. In contrast, no positive
selection was observed in the evolution of mammalian or grass
CenH3 [24]. The targeting of Drosophila CenH3
CID to centromeric
regions is dependent on the Loop 1 region, and heterologously
expressed CenH3 proteins from yeast and mammals did not
localize to centromeres in Drosophila [25]. On the other hand, it
was shown that budding yeast CenH3
Cse4 could structurally and
Figure 4. A fraction of Drosophila Chd1 null embryos displays
aberrant nuclear morphology and mitotic defects. A) Schematic
representation of the generation of Chd1 null embryos. B) The Chd1
mutation occasionally leads to the appearance of irregularly sized and
arranged nuclei. C) Mitotic defects, such as lagging chromosomes and
disorganized spindles (D), were observed in 15.6% of mutant embryos
(n=295) in contrast to only 1% (n=209) of wild-type embryos. DNA
was stained with DAPI (B, C), mitotic spindles were visualized by
staining with an antibody against a-tubulin (D). Scale bars =10 mm.
doi:10.1371/journal.pone.0010120.g004
Figure 5. CenH3
CID loading is not compromised in Chd1 null
embryos. A) Embryos from wild-type and Chd1 null flies were stained
with anti-CenH3
CID antibodies (green). DNA was visualized with DAPI
(red). B) Quantification of signal intensities of CenH3
CID foci in wild-type
and Chd1 null embryos (5 embryos each) as described in Material and
Methods. CenH3
CID signals have similar intensities indicating that CHD1
has no impact on CenH3
CID loading.
doi:10.1371/journal.pone.0010120.g005
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CENP-A [26]. Hence,
species-specific structural differences in the CenH3 proteins, such
as the long N-terminal tail region that is unique to Drosophila
CenH3
CID, might result in the use of different assembly
machineries. It is interesting to note in this context that the
human CenH3
CENP-A-specific chaperone HJURP, which was
recently identified to bind directly to CenH3
CENP-A and to be
required for CenH3
CENP-A incorporation into chromatin [27,28],
appears to lack orthologs in Drosophila and Caenorhabditis but shares
similarities with the fungal CenH3
Cnp1-specific chaperone Scm3
[29]. In Drosophila, the H3.3 specific chaperone HIRA was found
to be required for the assembly of the histone variant H3.3 into
paternal pronuclear chromatin [30]. We discovered a similar
requirement for CHD1, suggesting that CHD1 and HIRA could
cooperate in the H3.3 assembly pathway [5]. In an analogous
manner, it is possible that CHD1 and HJURP might cooperate in
the assembly of CenH3
CENP-A in vertebrates and fungi. In
Drosophila, however, where there might be no HJURP, CHD1
might have lost a function in centromeric chromatin assembly and
other factor(s) might have taken over its role. Intriguingly, a recent
screen for CID localization-deficient genes in Drosophila identified
CAL1 and CENP-C to be necessary for CenH3
CID assembly at
the centromere [20]. The CAL1 protein is well conserved within
Drosophilids but appears to lack homologues in other species.
Although the exact role of CAL1 in centromeric chromatin
assembly remains unclear, it was shown that CAL1 interacts with
CenH3
CID and CENP-C in mononucleosomal chromatin frac-
tions. Moreover, loss of CAL1 prevented centromeric localization
Figure 6. Recruitment of kinetochore components is not disturbed in the absence of CHD1. Wild-type and Chd1 null embryos were
stained with antibodies against a-tubulin (blue) and either the inner kinetochore protein CENP-C (A) or the outer kinetochore protein BubR1 (B; both
in green). DNA was counterstained with propidium iodide (red). Neither CENP-C nor BubR1 show apparent localization defects in the absence of
CHD1. Scale bars =10 mm.
doi:10.1371/journal.pone.0010120.g006
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CID and resulted in delocalization of
CENP-C [20]. The hSNF2-containing ATP-dependent remodeling
factor RSF was recently reported to interact with CenH3
CENP-A
mononucleosomes in human cells and to play a role in the
incorporation of CenH3
CENP-A [21]. In Drosophila, RSF has been
implicated in the incorporation of the histone H2A variant H2Av.
Defects in centromeric chromatin formation have not been
observed in dRsf1 mutant flies [31]. It is possible, however, that
robust compensation mechanisms in Drosophila so far have hindered
the identification of molecular motor proteins dedicated to the
assembly of centromeric nucleosomes. Future studies using
combined knock-down of different remodeling factors with histone
chaperones, such as CAF-1 p55 [32], might therefore contribute to
the elucidation of the role of ATP-dependent motor proteins in
centromeric chromatin formation.
Materials and Methods
Fly strains
To obtain Chd1 null embryos Df(2L)Chd1
1/Df(2L)Exel7014
virgin females were mated to wild type males as described [5].
Embryos were collected at 0–1 h or 0–2 h after egg deposition
at 25uC and immediately processed for immunofluorescence
staining.
Generation of a stable EGFP-CID cell line
The coding sequence of EGFP was cloned into NheI/SacII
digested vector pMT-LacZ (Invitrogen) yielding vector pMT-
EGFP. Since pMT-LacZ has no NheI site, this site had been
generated by inserting a double stranded oligonucleotide contain-
ing an NheI site into the KpnI/SpeI sites of the vector. The CID
coding region was amplified by PCR from genomic DNA derived
from wild-type flies and cloned into BglII/SacII digested vector
pMT-EGFP in frame with EGFP to give an N-terminal fusion
product of EGFP with CID (pMT-EGFP-CID). To generate stably
transformed cell lines, Drosophila S2 cells [33] were co-transfected
with the pMT-EGFP-CID expression vector and pCo-Hygro
(Invitrogen) using Effectene transfection reagent (Qiagen). Stably
transfected cells were selected in the presence of 0.75 mg/ml
hygromycin B in Schneider’s Drosophila medium (Lonza). EGFP-
CID expression was induced by addition of CuSO4 to a final
concentration of 750 mM in growth medium for 24 h and
monitored by western blot analysis of total cell lysates. Low
amounts of EGFP-CID expression were obtained in uninduced
cells due to some leakiness of the promoter.
dsRNA treatment of S2 cells
To generate dsRNA probes for RNAi, DNA fragments
corresponding to nt 70–599 (529 bp) and nt 1878–2306 (429 bp)
of Drosophila CHD1 mRNA and to nt 832–1319 (488 bp) and nt
3684–4178 (495 bp) of Drosophila CENP-C mRNA, respectively,
were amplified by PCR with primers containing T7 promoter
sequences. The PCR products were used as templates for in vitro
transcription with the MEGAscript Kit (Ambion) according to the
manufacturer’s instructions. After purification of the RNA
products by LiCl precipitation, annealing of RNA strands was
performed by heating the sample to 65uC for 30 min and
subsequent slow (4 h) cooling to room temperature. RNAi
treatment was performed by incubating 1610
6 cells with a
mixture of 10 mg each of the two dsRNA probes for up to 8 days
with changes of medium containing fresh dsRNA at days 3 and 5.
Cells were harvested at different time points and processed for
western blot, immunofluorescence staining or FACS analysis.
Western blot analysis
For protein expression analyses whole cell lysates were
prepared from S2 cells by harvesting the cells into RIPA buffer
( 5 0 m MT r i s - H C lp H 8 ,1 5 0 m MN a C l ,1 %N P - 4 0 ,0 . 5 %
deoxycholate, 0.1% SDS, 10 mM NaF, 0.5 mM EDTA, 10%
glycerol). Samples were frozen and thawed and subsequently
incubated with 25 U/ml benzonase (Novagen) for 30 min at
room temperature in the presence of protease inhibitors to release
chromatin-bound proteins. Extracts were cleared by centrifuga-
tion at 14 000 rpm for 10 min and aliquots (60 mg total protein)
were electrophoresed in 6% and 12% SDS-polyacrylamide gels.
Separated proteins were blotted and incubated with the following
primary antibodies: anti-CHD1pep 1:2000 (raised in rabbit
against a mixture of two peptides corresponding to amino acids
12–26 and 1805–1819, respectively, of the CHD1 sequence;
Figure S1A), anti-CID (Abcam) 1:3000, anti-ISWI 1:2000 and
anti-CAF1 p55 1:24 000 (gifts of Dr. J.T. Kadonaga). As a
secondary antibody peroxidase-conjugated anti-rabbit IgG (GE
Healthcare) at 1:10 000 was used. Detection of antigen-antibody
complexes was performed with the ECL Plus system (GE
Healthcare). Band intensities were quantified using Adobe
Photoshop CS3.
Micrococcal nuclease treatment and immunoprecipitation
Preparation of mononucleosomal fractions was performed
according to Wysocka et al. [34]. Briefly, 4610
8 S2 cells were
collected, washed with phosphate-buffered saline (PBS) and
resuspended at 4610
7 cells/ml in buffer A (10 mM Hepes/
KOH pH 7.9, 10 mM KCl, 1.5 mM MgCl2, 0.34 M sucrose,
10% glycerol, 1 mM DTT, protease inhibitor cocktail [Roche]).
After addition of Triton X-100 to 0.1% final concentration, cells
were homogenized and centrifuged for 5 min at 13006g. The
nuclear pellet was washed with 1 ml buffer A and subsequently
lysed in 1 ml of buffer B (3 mM EDTA, 0.2 mM EGTA, 1 mM
DTT, protease inhibitor cocktail). Nuclei were centrifuged for
5 min at 17006ga t4 uC, and the insoluble chromatin pellet was
resuspended in 0.2 ml buffer M (10 mM Tris/HCl, pH 7.6,
10 mM KCl, 1.5 mM CaCl2; prewarmed to 25uC). 1U of
micrococcal nuclease (Sigma) was added and digestion was
performed for 15 min at 25uC. The reaction was stopped by
addition of 1 mM EGTA, and solubilized chromatin was
separated from insoluble components by centrifugation at
17006g for 5 min. An aliquot of the supernatant was deprotein-
ized by Proteinase K digestion and phenol-chloroform extraction.
DNA was precipitated, redissolved in 5 ml gel loading buffer and
electrophoresed on a 1% agarose gel to check for predominant
release of mononucleosomes. The remainder of the supernatant
was adjusted to 0.5 ml with buffer C (15 mM Tris/HCl, pH 7.6,
150 mM NaCl, 1 mM EDTA, 1 mM DTT, protease inhibitor
cocktail) and incubated over night at 4uC with either anti-GFP or
anti-CHD1 antibodies preadsorbed to protein A sepharose beads.
Immunoprecipitates were washed with buffer C and eluted by
boiling the beads in 2x SDS sample buffer for 5 min. Aliquots of
input, supernatant and eluates were subjected to immunoblot
analysis.
Preparation of nuclear extracts
S2 control cells and S2 cells treated for 6 days with dsRNA
targeting CHD1 (7610
7 cells each) were used to prepare whole
cell lysate, nuclei, high-salt nuclear extract and chromatin core
fractions exactly as described by Perpelescu et al. [21]. Aliquots of
each cellular fraction were subjected to SDS PAGE and
immunoblotting.
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S2 cells were harvested and then allowed to settle on cover slips
for 1 h. Attached cells were washed with PBS, fixed with 3.7%
formaldehyde/0.3% Triton X-100 in PBS for 12 min and
subsequently blocked with 1% BSA in PBS. Some cells were
treated with 0.1% Triton X-100 for 2 min prior to fixation in
order to reduce the amount of soluble antigen. To generate
spreads of mitotic chromosomes S2 cells were incubated in
0.05 mg/ml colcemid (Gibco) for 6 h before harvesting. Cells were
resuspended in cold 75 mM KCl for 10 min and subsequently
centrifuged for 5 min at 4uC. Cells were resuspended in 75 mM
KCl, centrifuged onto 8-well poly-lysine coated glass slides and
fixed with 5% formaldehyde/0.3% Triton-X-100 in PBS for
10 min. Blocking was in 1% BSA/PBS for 1 h at room
temperature.
Primary antibody incubation was performed in 1% BSA/PBS
overnight at 4uC; secondary antibody incubation was carried out
at room temperature for 1 hour. Cells were repeatedly washed
with PBS, DNA was counterstained with DAPI and cells were
mounted in Vectashield (Vector Laboratories, Inc.). Drosophila
embryos were dechorionated and fixed in methanol as previously
described [35]. For immunostaining, embryos were rehydrated
overnight in 0.15% TBST (50 mM Tris-HCl pH 8, 150 mM
NaCl, 0.15% Triton X-100). They were then incubated with
primary antibodies in 0.15% TBST for 12 h at 4uC and washed
three times (20 min each) in 0.3% TBST before staining with the
secondary antibodies for 12 h at 4uC. Embryos were subsequently
rinsed three times (20 min each) in 0.3% TBST and incubated for
2 h in 2 mg/ml RNase A solution at 37uC. Following a 10 min
wash in 0.3% TBST, embryos were incubated at room
temperature for 45 min with propidium iodide (5 mg/ml in
0.15% TBST) or 10 min with DAPI (0.5 mg/ml in 0.15% TBST).
Finally, embryos were washed in 0.15% TBST several times and
mounted in Vectashield (Vector Laboratories, Inc.).
The following primary antibodies were used: Mouse monoclo-
nal anti-a-tubulin (1:500; Sigma), mouse monoclonal anti-GFP
antibody (1:200 and 1:500; Millipore), rabbit polyclonal anti-CID
antibody (1:50 and 1:300; Abcam), rabbit polyclonal anti-CID
antibody (1:500; gift of Dr. S. Henikoff), rabbit polyclonal anti-
CENP-C antibody (1:5000; gift of Dr. Ch. Lehner), rabbit
polyclonal anti-CHD1 antibody (1:50 and 1:200; gift of Dr. R.
Perry), rabbit polyclonal anti-CHD1pep antibody (1:250) [Note:
the specificity of both anti-CHD1 antibodies for CHD1 was
confirmed by immunostaining of CHD1-deficient embryos laid by
Chd1-null females and of CHD1-depleted S2 cells (Figure S1B and
C)], mouse anti-Flag antibody (1:500; Sigma), rabbit polyclonal
anti-BubRI antibody (1:3000; gift of Dr. C. Sunkel). Appropriate
secondary antibodies conjugated with Alexa 350, 488 or 594
(Molecular Probes) were used at 1:1000.
Confocal microscopy
Images were taken on a confocal laser scanning microscope
(Axiovert 100 LSM510, Carl Zeiss or SP5, Leica) equipped with a
636/1.40 oil immersion objective. Z series of optical sections were
obtained and projected along the z axis to obtain a general view of
the specimen. Images were processed using LSM Image Browser
(version 4.2) software, ImageJ (version 1.43f) and Adobe Photo-
shop CS3.
Quantification of imaging data
Quantification of pixel intensities was performed using ImageJ
(version 1.43f) software. To determine CenH3
CID fluorescence
signal intensities in S2 cells, z stacks were generated of 8 to 10
optical sections in the green channel using maximum intensity
projection mode. For CenH3
CID intensity measurements of stage 4
embryos, z stacks were generated of 3 to 4 optical sections in the
green channel using maximum intensity projection mode. Nuclear
regions were selected manually and multiplied with a binary mask
of the respective ROIs to obtain the mean centromeric
fluorescence intensity. For the quantification of CenH3
CID signals
in Drosophila embryos the absolute centromeric fluorescence
intensities per ROI were calculated by multiplying the background
corrected mean centromeric pixel intensities with the number of
evaluated pixels within the ROI. The obtained values were
normalized against the number of centromeric foci. Results from
mutant embryos and RNAi-treated S2 cells, respectively, were
normalized against wild-type values.
Supporting Information
Figure S1 Characterization of CHD1 antibodies. A) Schematic
representation of the CHD1 protein sequence (top). Polyclonal
antibodies were raised in rabbits against a mixture of two peptides
corresponding to N-terminal (aa 12–26) and C-terminal (aa 1805–
1819) sequences, respectively, of Drosophila CHD1. The positions
of the peptides are indicated. Peptide-specific antibodies were
affinity purified and tested by immunoblotting (bottom). Aliquots
of purified recombinant CHD1 (Flag-CHD1), S2 whole cell
extract and embryonic extract were loaded onto a 6% SDS
polyacrylamide gel, blotted and incubated with the antibodies at
1:1000 dilution. Signal detection was performed using ECL PLUS
reagent (GE Healthcare). B) Anti-CHD1 (top) and anti-CHD1pep
(bottom) antibodies (green) were incubated with Chd1-deficient
haploid blastoderm embryos to test for unspecific cross-reactions.
DNA was counterstained with DAPI (red). Weak background
staining was observed in the cytoplasm, whereas nuclei were
devoid of signal. C) Immunostaining of S2 cells with antibodies
against CHD1 (green) as described in B). Cells were either
incubated with dsRNA targeting CHD1 (CHD1 RNAi) or water
(control) for 6 days before fixation and staining. DNA was
visualized with DAPI (blue). D) S2 cells were transiently
transfected with Flag-CHD1 and stained with antibodies against
Flag (red) and CHD1 (green). DNA was counterstained with DAPI
(blue). Flag-CHD1 expressing cells (arrowheads) show stronger
anti-CHD1 signals than cells in which Flag-CHD1 is not
detectable (asterisks).
Found at: doi:10.1371/journal.pone.0010120.s001 (2.98 MB TIF)
Figure S2 CHD1 does not colocalize with centromeres in
Drosophila S2 cells. A) S2 cells stably expressing EGFP-tagged
CenH3
CID were treated (bottom panels) or not treated (top panels)
with Triton X-100 before fixation to reduce the amounts of soluble
protein. Cells were stained with anti-CHD1 peptide antibodies
(red) and anti-GFP (green) antibodies to detect CenH3
CID. DNA is
shown in blue. CHD1 displays nuclear staining during interphase
and redistributes to the cytoplasm during mitosis. Colocalization of
CenH3
CID and CHD1 was never observed. B) S2 cells stably
expressing Flag-tagged CHD1 were stained with anti-Flag (red)
and anti-CenH3
CID (green) antibodies. Colocalization of Cen-
H3
CID and CHD1 was never observed.
Found at: doi:10.1371/journal.pone.0010120.s002 (5.16 MB TIF)
Figure S3 Depletion of CENP-C in S2 cells results in loss of
CenH3
CID from centromeres. A) S2 cells were treated with
dsRNA targeting CENP-C for 4 days. Whole cell extracts from
control and RNAi cells were subjected to immunoblotting with
antibodies against CENP-C (top) and actin (bottom). CENP-C
protein levels were reduced to undetectable amounts. B) CENP-C
RNAi treated and control cells were stained with anti-CID
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were performed in cells at day 4 of RNAi treatment. C) Signal
intensities of centromeric foci after staining with anti-CenH3
CID
antibodies were quantified as described in Materials and Methods.
Error bars denote standard deviations of signals obtained from 148
untreated and 115 RNAi-treated nuclei, respectively, after 4 days
of dsRNA incubation.
Found at: doi:10.1371/journal.pone.0010120.s003 (2.45 MB TIF)
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